Return to Article Details Active targeting of rhenium (iv) oxide (ReO2), rhenium trioxide (ReO3) and rhenium (vii) oxide (Re2O7) nanoparticles as cancer therapeutics swell-up to kill cancer cells under synchrotron and synchrocyclotron radiations Download Download PDF